Trials / Recruiting
RecruitingNCT06880380
The Efficacy and Safety Study of CAR-T Cells for Functional Cure in HIV-1/AIDS Patients
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 3 (estimated)
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Autologous CAR-T cell therapy in HIV-1/AIDS patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | HIV-CAR-T | Intravenous Infusion of CAR-T Cells |
Timeline
- Start date
- 2025-09-01
- Primary completion
- 2026-03-31
- Completion
- 2026-07-01
- First posted
- 2025-03-17
- Last updated
- 2026-03-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06880380. Inclusion in this directory is not an endorsement.